The latest update on Ginkgo Bioworks Holdings has reset its fair value anchor from US$12.00 to US$10.00, reflecting a more cautious stance on the stock's long term potential. This comes alongside a ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 10, 2026 / New to The Street, the nationally syndicated business ...
20h
The Living Urn’s Tree Nurseries are Well Stocked in Anticipation of Continued Strong Demand in 2026
The company has thousands of trees and flowering shrubs in stock to supply an increase in demand for its unique ...
Hisamitsu Pharmaceutical Co. Inc. President and CEO Kazuhide Nakatomi is leading a management buyout to take the company private, citing mounting drug pricing pressures and tougher listing ...
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
As of Friday, January 09, Atara Biotherapeutics, Inc.’s ATRA share price has dipped by 20.36%, which has investors questioning if this is right time to buy.
Opendoor stock is rising after Trump’s $200 billion mortgage-bond plan could lower rates and reignite homebuying demand.
SL Bio files Form F-4 with SEC to merge with Horizon Space Acquisition II Corp. Valued at $5.7B, SL Science Holding Limited ...
Barchart on MSN
Here's what to expect from Bio-Techne's next earnings report
Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...
Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...
M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming ...
As of Thursday, January 08, BridgeBio Oncology Therapeutics, Inc.’s BBOT share price has surged by 7.81%, which has investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback